Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Ludwig-Maximilians - University of Munich |
---|---|
Information provided by: | Ludwig-Maximilians - University of Munich |
ClinicalTrials.gov Identifier: | NCT00471744 |
We hypothesize that Levetiracetam is as effective as Sulthiame in the treatment of children with BECTS. Patients entering the HEAD-Studie are either treated with Leveitracetam or Sulthiame over a 6 months period. Patients are equally randomised to one of the two treatment regimens. Administration of medication as blinded capsules.
Condition | Intervention | Phase |
---|---|---|
Epilepsy, Rolandic |
Drug: Treatment with levetiracetam or sulthiame over a six-month period. |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | HEAD-TO-HEAD Evaluation of the Antiepileptic Drugs Levetiracetam (LEV) vs. Sulthiame (STM) in a German Multi-Centre, Doubleblind Controlled Trial in Children With Benign Epilepsy With Centro-Temporal Spikes |
Estimated Enrollment: | 120 |
Study Start Date: | June 2006 |
Estimated Study Completion Date: | December 2007 |
Ages Eligible for Study: | 5 Years to 14 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: F Heinen, Prof. | 0049-89-5160 ext 7851 | florian.heinen@med.uni-muenchen.de |
Contact: M Bonfert | 0049-89-5160 ext 7852 | michaela.bonfert@med.uni-muenchen.de |
Germany | |
Dr. von Haunersches Kinderspital | Recruiting |
München, Germany, 81371 |
Principal Investigator: | F Heinen, Prof. | Ludwigs-Maximilians-Universität München |
Study ID Numbers: | 2005-004468-22, ISRCTN 97864911 |
Study First Received: | May 8, 2007 |
Last Updated: | May 8, 2007 |
ClinicalTrials.gov Identifier: | NCT00471744 |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
benign epilepsy pediatrics children |
rolandic epilepsy levetiracetam sulthiame |
Epilepsies, Partial Sulthiame Epilepsy, Rolandic Epilepsy |
Central Nervous System Diseases Etiracetam Brain Diseases |
Nootropic Agents Therapeutic Uses Nervous System Diseases |
Central Nervous System Agents Pharmacologic Actions Anticonvulsants |